Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis.

52W Range

7thpctl

Volume

1.25×avg

Market Cap

1.76TKRW

P/E Ratio

-5.9TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

Kolon TissueGene, Inc.

950160.KQKOSDAQ·KRW·Closed

Kolon TissueGene, Inc.

950160.KQKOSDAQ·KRW·Closed

$20800.00

−3.93%

$20800.00

−$850.00 (3.93%)

52W Range

7thpctl

Volume

1.25×avg

Mkt Cap

1.76TKRW

P/E

-5.9TTM

Div Yield

–ann

950160.KQ: Kolon TissueGene, Inc. Company Profile & Overview | finqOS